<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Enhanced proliferation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> progenitors is abrogated by <z:mp ids='MP_0006042'>increased apoptosis</z:mp> of their progeny in vivo </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated whether bone marrow mononuclear cells (BMMNC) of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients also showed enhanced proliferation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in vitro in comparison with <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and <z:mpath ids='MPATH_458'>normal</z:mpath> BM (NBM) </plain></SENT>
<SENT sid="2" pm="."><plain>NBM showed a decrease in the number of clusters in time due to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of clusters and due to development of clusters into colonies with low apoptotic level </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients, about two-fold more clusters have developed at day 4, and in contrast with NBM, the total number of clusters at day 7 remained high in spite of an increasing percentage of apoptotic clusters (from 52 to 76%) in combination with more colony formation </plain></SENT>
<SENT sid="4" pm="."><plain>The number of clusters and colonies showed a sharp decrease at day 10 because of persistently high <z:mpath ids='MPATH_3'>apoptosis</z:mpath> at cluster level and increasing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in colonies </plain></SENT>
<SENT sid="5" pm="."><plain>BMMNC of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients showed a decreased proliferation with enhanced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> at cluster level in contrast to a relatively low apoptotic levels in the colony-forming cells </plain></SENT>
<SENT sid="6" pm="."><plain>This data show that increased proliferation is abrogated by enhanced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, whereas <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> showed decreased proliferation with a low level of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in colony-forming cells </plain></SENT>
<SENT sid="7" pm="."><plain>These growth profiles of BMMNC are independent of stromal influences and may represent intrinsic features of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> progenitors and accessory cell interactions </plain></SENT>
</text></document>